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Clostridioides difficile is the leading cause of antibiotic-associated diarrhea and is capable
of causing severe symptoms, such as pseudomembranous colitis and toxic megacolon.
An unusual feature of C. difficile is the distinctive production of high levels of the
antimicrobial compound para-cresol. p-Cresol production provides C. difficile with a
competitive colonization advantage over gut commensal species, in particular, Gram-
negative species. p-Cresol is produced by the conversion of para-hydroxyphenylacetic
acid (p-HPA) via the actions of HpdBCA decarboxylase coded by the hpdBCA operon.
Host cells and certain bacterial species produce p-HPA; however, the effects of p-HPA on
the viability of C. difficile and other gut microbiota are unknown. Here we show that
representative strains from all five C. difficile clades are able to produce p-cresol by two
distinct mechanisms: (i) via fermentation of p-tyrosine and (ii) via uptake and turnover of
exogenous p-HPA. We observed strain-specific differences in p-cresol production,
resulting from differential efficiency of p-tyrosine fermentation; representatives of clade 3
(CD305) and clade 5 (M120) produced the highest levels of p-cresol via tyrosine
metabolism, whereas the toxin A-/B+ isolate from clade 4 (M68) produced the lowest
level of p-cresol. All five lineages share at least 97.3% homology across the hpdBCA
operon, responsible for decarboxylation of p-HPA to p-cresol, suggesting that the limiting
step in p-cresol production may result from tyrosine to p-HPA conversion. We identified
that elevated intracellular p-HPA, modulated indirectly via CodY, controls p-cresol
production via inducing the expression of HpdBCA decarboxylase ubiquitously in C.
difficile populations. Efficient turnover of p-HPA is advantageous to C. difficile as p-HPA
has a deleterious effect on the growth of C. difficile and other representative Gram-
negative gut bacteria, transduced potentially by the disruption of membrane permeability
and release of intracellular phosphate. This study provides insights into the importance of
HpdBCA decarboxylase in C. difficile pathogenesis, both in terms of p-cresol production
and detoxification of p-HPA, highlighting its importance to cell survival and as a highly
specific therapeutic target for the inhibition of p-cresol production across C.
difficile species.
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Clostridioides difficile is a major nosocomial pathogen that causes
significant mortality and morbidity globally, with an estimated
12,800 deaths in 2017 in the USA alone (CDC, 2019). C. difficile
primarily affects patients who have been treated with broad
spectrum antibiotics for an unrelated condition, resulting in
damage to the gut microbiome and a resultant loss of
colonization resistance to C. difficile, with patients who receive
longer courses of therapy at a greater risk than those receiving short
courses (Brown et al., 2020). While treatment of C. difficile is
effective with either metronidazole, vancomycin, or fidaxomicin, a
major feature of C. difficile infection (CDI) is the high proportion of
patients (20–30%) who suffer from recurrence (often multiple
recurrences) either as a result of reinfection or relapse (Vardakas
et al., 2012). As a result, treatments that are highly specific for C.
difficile which prevent recurrence are a current imperative.
Para-cresol (4-methylphenol) is an antimicrobial compound
produced by C. difficile either through the fermentation of p-
tyrosine (4-hydroxyphenylalanine) via the intermediate para-
hydroxyphenylacetic acid (p-HPA) (Scheline, 1968; Dawson et al.,
2011) or via the conversion of exogenous p-HPA to p-cresol
(Harrison et al., 2020). The conversion of p-HPA to p-cresol
occurs via the actions of the HpdBCA decarboxylase (Selmer and
Andrei, 2001), encoded by the hpdBCA operon (Dawson et al.,
2011). This operon is formed of three genes, each encoding a
subunit of decarboxylase, with all three subunits being required for
p-cresol production (Dawson et al., 2011). C. difficile is highly
tolerant to p-cresol, with the hypervirulent R20291 [Ribotype
(RT) 027] strain significantly more tolerant than the 630 strain
(RT012) (Dawson et al., 2011). p-cresol selectively inhibits the
growth of Gram-negative bacteria of the Gammaproteobacteria
class, including Escherichia coli, Proteus mirabillis, and Klebsiella
oxytoca, while Gram-positive species such as Lactobacillus
fermentum, Enterococcus faecium, and Bifidobacterium
adoscelentis are significantly more tolerant to p-cresol (Passmore
et al., 2018). Furthermore, a p-cresol null mutant has a fitness defect
in a mouse relapse model of CDI (Passmore et al., 2018),
highlighting the importance of this pathway to C. difficile during
infection. p-cresol production among the resident gut bacteria is
unusual, with only three other identified bacterial species producing
p-cresol to relatively high levels: Blautia hydrogenotrophica,
Olsenella uli, and Romboutsia lituseburensis (Saito et al., 2018).
These gut commensals produced more p-cresol than C. difficile
when cultured in rich media over a period of 6 days (Saito et al.,
2018); however, C. difficile is inefficient at metabolizing p-tyrosine to
produce p-cresol in rich media (Dawson et al., 2011) and requires
the addition of p-HPA, an intermediate in the pathway (Dawson
et al., 2011; Harrison et al., 2020). Therefore, the conditions used by
Saito et al. likely hindered the production of p-cresol by C. difficile
(Saito et al., 2018). While we have demonstrated the importance of
p-cresol to C. difficile virulence, the effect of p-HPA on growth and
pathogenesis is unknown. p-HPA is produced via p-tyrosine
metabolism by a variety of bacteria, including Acinetobacter,
Klebsiella, and Clostridium species as well as being produced by
mammalian cells, and is detected in all human tissues and biofluids
(Wishart et al., 2018). We recently showed that exogenous p-HPAFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 2induces expression of the hpdBCA operon, which, in turn, induces
high-level p-cresol production (Harrison et al., 2020). Therefore,
exogenous p-HPA produced either by human cells, the gut
microbiome, or a combination of both may provide C. difficile
with a reservoir of p-HPA to enhance p-cresol production and thus
provide C. difficile with a competitive advantage over a number of
commensal species, which are vital for colonization resistance.
The C. difficile species is encompassed by five distinct clades
(Griffiths et al., 2010; Stabler et al., 2012). Clade 1 contains strain
630, a ribotype RT012 strain isolated from a patient, in the 1980s,
with severe pseudomembranous colitis and the first strain to be
genome sequenced; however, this clade also contains a diverse
range of both toxigenic and nontoxigenic strains (Wust et al.,
1982; Knight et al., 2015). Clade 2 includes hypervirulent strains
such as R20291 (RT027), which was responsible for significant
outbreaks worldwide from 2004 (Loo et al., 2005; Warny et al.,
2005) and remains a prevalent global ribotype (Tamez-Torres
et al., 2017; Freeman et al., 2018; PHE, 2019; Marujo and Arvand,
2020). Clade 3 includes strain CD305 (RT023), a recently
emerged hypervirulent lineage prevalent in the UK (Shaw
et al., 2020). Clade 4 strains, including M68, a toxin A-negative
RT017 strain (PHE, 2019), are prevalent in Asia (van den Berg
et al., 2004; Kim et al., 2010; Kim et al., 2016; Jin et al., 2017).
Finally, Clade 5, including strain M120 (RT078), has been
commonly isolated in animals. However, more recently, RT078
caused human outbreaks in the Netherlands (Goorhuis et al.,
2008) and is one of the most common community-acquired
ribotype in Europe (Bauer et al., 2011; PHE, 2019). There have
been suggestions of a further three clades of C. difficile (C-I, C-II,
and C-III), with C-I identified as being able to cause CDI
(Ramıŕez-Vargas and Rodrıǵuez, 2020). However, these cryptic
clades fall well below the average nucleotide identity analysis
threshold, indicating that these strains are, in fact, likely to be
another species (Knight et al., 2021).
In this study, we demonstrate that the representative strains
from all five clades of C. difficile were found to produce high
levels of p-cresol, with the expression of the hpdBCA operon
induced in the presence of p-HPA. The production of HpdBCA
decarboxylase was ubiquitous across all cells within a population
of C. difficile in response to p-HPA. Exogenous p-HPA inhibits C.
difficile growth and enhances sporulation, as well as inhibiting
the growth of a number of representative commensal bacterial
strains from the gut, especially Gram-negative species.
Potentially, p-HPA induces perturbations in the cell membrane
integrity of these bacteria through a combination of reduced pH
and cell membrane disruption. These findings together
demonstrate the importance of conversion of p-HPA to
p-cresol and validates it as a specific therapeutic target that
should be effective against all C. difficile strains.MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
All bacterial strains used in this study are listed in Table 1.
The routine growth of all species was carried out using Brain
Heart Infusion (Oxoid) supplemented with 5 g L-1 yeast extractOctober 2021 | Volume 11 | Article 757599
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grown in anaerobic conditions in a Modular Atmosphere
Control System 500 (Don Whitney Scientific) at 37°C. All
media underwent a minimum of 4 hour pre-equilibration in
anaerobic conditions prior to inoculation.
Growth Analysis
The growth of C. difficile strains (630Derm and 630Derm hpdC::
CT) and intestinal species (Escherichia coli, Klebsiella oxytoca,
Proteus mirabillis, Bifidobacterium adoscelentis, Lactobacillus
fermentum, and Enterococcus faecium) was assessed for a
minimum of 8 h. Each strain was grown overnight in BHIS
before being diluted back to OD590nm of 0.5. Thereafter, 1ml of
which was added to 10 ml of BHIS supplemented with 0, 1, 2, 3,
and 4 mg/ml p-HPA. To establish whether the toxicity of p-HPA
was related to acidification of the media, the pH of BHIS media
supplemented with p-HPA (0, 1, 2, 3, and 4 mg/ml) was
measured using a Mettler Toledo Seveneasy pH meter. To
mimic the acidity that results from p-HPA supplementation,
the pH of BHIS was adjusted using hydrochloric acid to match
the pH of media supplemented with 0, 1, 2, 3, and 4 mg/ml
p-HPA; these correspond to pH levels of 6.6, 6.2, 5.8, and 5.4,
respectively. Furthermore, following the completion of growth
curves at this pH, the C. difficile cultures were filter-sterilized
using 0.22-µm filter (Millipore), and the pH of the supernatant
was tested. All growth curves were carried out in a minimum of
biological triplicate with OD590nm determined every hour for 8 h,
with a final reading at 24 h with the exception of C. difficile grown
in the presence of p-HPA, which was not read at 24 h due to C.
difficile cultures clumping in the presence of p-HPA, making an
accurate OD590nm reading impossible.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3Sporulation Assays
Sporulation assays were carried out by growth of 630Derm and
630Derm hpdC::CT in BHIS media supplemented with 0, 1, 2, and 3
mg/ml p-HPA. Each strain was grown overnight in BHIS and then
back-diluted to OD590nm of 0.5, 1 ml of which was added to 10 ml of
BHIS supplemented with 0, 1, 2, or 3 mg/ml p-HPA. These cultures
were grown for 24 h. Where cultures had aggregated in the presence
of p-HPA, these aggregations were dispersed by vigorous pipetting
and vortexing. Colony-forming units per milliliter were determined
for the total cell count and the spore count using 1 ml of the culture
for each. Spore counts were determined from the total cell counts by
heat-killing of vegetative cells at 65°C for 25 min. Dilutions were
plated onto BHIS supplemented with 0.1% sodium taurocholate in
technical triplicate and counted on the following day. Sporulation
assays were carried out in a biological triplicate. Sporulation
percentages were calculated and analyzed by Spearman rank–
order correlation. Statistical analysis by regression analysis was
carried out to determine significant differences between total cell
counts in each condition tested. Then, p <0.05 was considered
significantly different.
Phosphate Release Assay
This assay was carried out as per Passmore et al., (2018) using the
phosphate assay kit (Abcam). Briefly, the species to be tested
were grown overnight in 10 ml BHIS, 5 ml of which was pelleted
and washed twice in 5 ml Tris-buffered saline (TBS, 50 mM Tris-
HCl, pH 7.5, 150 mM NaCl) before suspension in 5 ml TBS.
OD590nm was measured, and the suspensions were back-diluted
to OD590nm of 1.0. Then, 500-µl aliquots were taken and pelleted
for 2 min at 17,000 x g, and the supernatant was removed. The
pellets were then re-suspended in 500 µl of TBS with 0, 1, 2, or 3TABLE 1 | Strains and plasmids used in this study.
Strain or plasmid Relevant features Source or reference
C. difficile strains
630Derm Erythromycin-sensitive strain of 630—clade 1 (Hussain et al., 2005)
630Derm PhpdB-CDS-SNAP 630Derm carrying SNAP-tag reporter fused via a linker to hpdB coding sequence This study
630Derm PhpdB-phoZ 630Derm knockout carrying hpdB phoZ transcriptional reporter (Harrison et al., 2020)
630Derm DcodY DcodY mutant of 630Derm (Tremblay et al., 2021)
630Derm DcodY PhpdB-phoZ codY knockout carrying hpdB phoZ transcriptional reporter This study
R20291 Representative strain—clade 2 (Stabler et al., 2012)
CD305 Representative strain—clade 3 (Stabler et al., 2012)
M68 Representative strain—clade 4 (Stabler et al., 2012)
M120 Representative strain—clade 5 (Valiente et al., 2012)
630Derm PhpdB-CDS-SNAP 630Derm carrying a translational fusion of the promoter and coding sequence of hpdB fused to a SNAP-tag This study
Gut commensal strains
Escherichia coli Dr. Simon Baines
Klebsiella oxytoca Dr. Simon Baines
Proteus mirabillis Dr. Simon Baines
Enterococcus faecium Dr. Simon Baines
Lactobacillus fermentum Dr. Simon Baines
Bifidobacterium adoscelentis Dr. Simon Baines
E. coli cloning strains
E. coli NEB5a General cloning New England Biolabs
E. coli CA434 Conjugation donor (Hussain et al., 2005)
Plasmids
pMTL84151 (Heap et al., 2009)
PhpdB-CDS-SNAP pMTL84151 carrying translational fusion of the promoter and coding sequence of hpdB joined to a SNAP-tag This study
PhpdB-phoZ pMTL84151 plasmid carrying transcriptional fusion of the native hpdBCA promoter to phoZ reporter (Harrison et al., 2020)October 2021 | Volume 11 | Article 757599
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TBS alone to determine the maximum intracellular phosphate
released, which was found by boiling the sample for 15 min.
After 30, 60, and 90 min, 100 µl was removed from the anaerobic
chamber and pelleted, and 30 µl of the supernatant was added to
170 µl H2O and 30 µl ammonium molybdate and malachite
green reagent in a 96-well plate. After the final 90 min, samples
were added to the reagent, and the plate was incubated at room
temperature for 30 min before the absorbance at OD650nm was
read by a Spectramax M3 plate reader. The final results were
calculated by the subtraction of OD650nm from the media control
from each of the media conditions. The pH of the TBS with 1, 2,
and 3 mg/ml p-HPA was measured to be pH 6.6, 4.1, and 3.8,
respectively. The phosphate release assays were repeated in TBS
with matched pH (to the p-HPA samples, using hydrochloric
acid). All assays were performed in technical duplicate and
biological triplicate. Statistical analysis was undertaken by
ANOVA using GraphPad Prism 8 software to compare
phosphate release in each condition to the TBS control. Then,
p <0.05 was considered significantly different.
RNA Extraction and qRT-PCR
Total RNA was isolated from all five representative C. difficile
strains grown in BHIS media up to OD590nm of 0.6 to 0.7;
RNA protect was added in a 1:1 ratio and incubated at 37°C
for 5 min. The cells were pelleted by centrifugation at 17,000 x g
at 4°C, and the pellets were stored immediately at -80°C. All
centrifugation steps were carried out at 4°C and 17,000 x g unless
otherwise indicated. Pellets were thawed and processed using the
RNAPro kit (MP biomedicals); 1 ml of RNAPro solution was
used to re-suspend the pellets and was transferred to Lysis Matrix
B tubes (MP Biomedicals) before undergoing ribolysis for 40 s
at 6.0 m/s using a FastPrep-24 Classic instrument (MP
Biomedicals). The sample was transferred to 300 µl chloroform
and centrifuged for 15 min, and the upper phase was transferred
to 100% ethanol and underwent DNA precipitation overnight at
-20°C. The samples were then centrifuged for 5 min, washed with
70% ethanol (made with nuclease-free dH2O), and re-
centrifuged. Finally, the pellets were resuspended in 50 µl of
DEPC-treated water which was stored at -80°C until further
processing. Then, 25 µl of extracted material was added to 20 U
Turbo DNase I (Thermofisher), 80 U RNasin plus RNase
inhibitor (Promega), 50 mM magnesium sulphate, 90 mM
sodium acetate, and DEPC water up to 150 µl. The samples
were incubated for 1 h at 37°C in a PCR thermocycler before the
addition of a further 20 U Turbo DNase and 80 U RNasin Plus,
followed by incubation for another hour at 37°C.
The DNase-treated samples underwent RNA purification
using the RNeasy kit (Qiagen). The samples were added to 350
µl RLT buffer and 200 µl 100% ethanol and then applied to a
RNeasy column and centrifuged for 15 s at 12,800 x g. Two wash
steps, using 500 µl RPE wash buffer, were carried out, followed by
drying of the column by centrifugation for 2 min. The RNA was
eluted in 17 µl DEPC water, the column was allowed to stand for
3 min before a 1 min centrifugation, and the elution step was
repeated twice to give an approximate volume of 50 µl eluted
RNA. The eluted RNA was tested for quality (260:280 nm ratio)Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 4and concentration using a Denovix DS-11 FX instrument
(Thermo scientific). Synthesis of cDNA was carried out with 1
µg of RNA using Superscript IV (Thermo scientific) as per the
instructions of the manufacturer. qRT-PCR was carried out
using the Kapa Sybr Fast kit (Roche), as per the instructions of
the manufacturer, on an ABI-7500 Fast system (Applied
Biosystems) using 2 µl of cDNA diluted 1:10 for hpdC and
1:100 for 16S rRNA (internal control). Gene expression was
normalized to 16S using the DDCt method described previously
(Livak and Schmittgen, 2001). 16S (rrs) was chosen as an internal
control as it is a widely used and accepted control, having been
shown to be among the most stable reference genes (Metcalf
et al., 2010). We observed less than one cycle variation in the 16S
control between the defined media (DM) and the DM
supplemented with p-HPA. qRT-PCR was carried out in
technical triplicate on five biological replicates. Regression
analysis was carried out using Stata16 to determine if fold
changes were significant for each strain in the presence of
p-HPA compared to the BHIS control and if fold changes in
the presence of p-HPA were significantly different.
High-Performance Liquid Chromatography
With Diode Array Detection
The five strains representing each clade of C. difficile (630Derm,
R20291, CD305, M68, and M120) as well as 630Derm and the
DcodY strains were grown overnight in defined media (DM). The
DM recipe used in this study was made by combining the salt,
trace salt, vitamin, and iron sulphate solutions from Cartman
and Minton (2010); however, we replaced the casamino acids
described by Cartman and Minton (2010) with defined amino
acids from the minimal media described by Karasawa et al.
(1995) as well as using the glucose solution at 11 mM from
Karasawa et al. (1995). The only addition to these published
minimal media is the p-tyrosine concentration, which was
increased to the maximum soluble concentration, 400 mg/l.
Each strain was grown overnight in DM and then back-diluted
on the following day to OD590nm of 0.5, 1 ml of which was used to
inoculate 10 ml of DM and DM with 2 mg/ml p-HPA, to answer
the following questions, respectively: are all five clades equally
efficient at producing p-cresol via (i) the fermentation of p-
tyrosine and (ii) via uptake and turnover of exogenous p-HPA?
Strains were grown for 8 h, with 1 ml samples taken after 4 and
8 h and at each time point the OD590nm was also taken, to allow
for p-HPA and p-cresol production to be normalized for growth.
Samples for high-performance liquid chromatography (HPLC)-
diode array detection (DAD) were filter-sterilized using 0.22 µm
filters before freezing at -80°C prior to the HPLC analysis.
The filter-sterilized samples were transferred to HPLC vials
and analyzed immediately by injecting onto the HPLC column.
Separations were achieved by utilizing an Acclaim 120
(Thermofisher), C18, 5 mm (4.6 × 150 mm), with the mobile
phase consisting of ammonium formate (10 mM, pH 2.7) and
menthol (v/v; 40:60) at a flow rate of 2 ml/min. p-HPA and p-
cresol were detected by the diode array detector (PDA; DAD
3000) set at 280 nm. Peak identity was confirmed by measuring
the retention time of commercially available p-HPA and p-cresol,
and determination of absorbance spectra was performed usingOctober 2021 | Volume 11 | Article 757599
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by Chromeleon (Dionex software) using known amounts of the
reference standards (0–100 mg/ml) dissolved in media and
injected onto the column, and the amount of p-HPA and p-
cresol in the samples was determined. Samples from three
independent biological replicates were analyzed compared to
media controls and standard curves. The limit of detection for p-
HPA and p-cresol are 0.001 and 0.0005 mg/ml, respectively. The
data was analyzed in GraphPad Prism 8, and statistical analysis
was performed in Stata16 using linear regression analysis;
p <0.05 was considered statistically significant.
phoZ Assays
To determine if reduced hpdBCA promoter activity was the
mechanism for reduced p-HPA turnover in 630Derm DcodY, a
phoZ transcriptional reporter fused to the hpdBCA promoter
sequence was used (PhpdB-phoZ) (Harrison et al., 2020).
The reporter plasmid was conjugated into 630Derm and
630Derm DcodY. Assays were carried out exactly as per
Harrison et al. (2020). Briefly, each strain was grown overnight
in BHIS before back-dilution to OD590nm of 0.5 and growth in 3:1
DM : BHIS for 3 h. The cultures were washed twice in fresh DM
before a final resuspension in 1 ml of DM, 100 µl of which was
added to 10 ml DM ±2 mg/ml p-HPA and grown for 4 h before
2-ml samples were taken, pelleted, and frozen before processing
for phoZ activity as per Harrison et al. (2020). Phosphatase
activity was calculated by the formula [OD420 nm – (OD550 nm ×
1.75)] × 1,000/t (min) × OD590 nm × volume of cells (ml).
Analysis of HpdB Expression and
Localization
To investigate the expression and localization of HpdB, a
translational fusion was constructed with the promoter region
of hpdBCA and the HpdB coding sequence joined via a linker to a
SNAP-tag carried in a pMTL84151 vector to give plasmid PhpdB-
CDS-SNAP. The construction of the plasmid was carried out in a
two-stage process. Firstly, Gibson cloning was used to insert the
hpdBCA promoter and coding sequence into plasmid
pMTL84151 (Table 1), followed by insertion of the linker and
SNAP-tag into the pMTL84151 carrying the hpdBCA promoter
and coding sequence (Table 1). All PCRs were carried out using
Phusion (NEB) as per the instructions of the manufacturer.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 5PCR products were run on a 1% agarose gel, the bands were
cut out and then purified using the Monarch gel extraction kit
(NEB), and ligation of PCR products was carried out using Hifi
master mix (NEB) as per the instructions of the manufacturer.
The primers used are listed in Table 2. The construction of the
plasmid was confirmed by Sanger sequencing before
electroporation into the conjugation strain of E. coli CA434
(Purdy et al., 2002). Conjugation was carried out using heat
shock for 5 min at 52°C as per Kirk and Fagan (2016), with
transconjugants selected by growth on BHIS with D-cycloserine
and cefoxitin (C. difficile supplement, Oxoid) and thiamphenicol
(15 µg/ml) (CCTm). Transconjugants were re-streaked once
more onto BHIS CCTm plates to ensure plasmid retention.
Confocal Microscopy
To prepare the slides for microscopy, overnight cultures of
630Derm PhpdB-CDS-SNAP were back-diluted to OD590nm of
0.5, and 1 ml was added to BHIS ±2 mg/ml p-HPA. These
cultures were grown for 4 h before 500 µl was removed and
added to 2.5 µl 50 nM TMR-Star and incubated anaerobically in
the dark for 30 min. Following incubation, the samples were
pelleted at 4,000 x g for 2 min and washed twice in 500 µl PBS;
after the second wash, approximately 20 µl PBS was left in the
tube and used to re-suspend the pellet. A 1-µl loop was used to
spread the culture onto a glass slide, which was allowed to air dry
for 1 min. Then, 10 µl of Vectashield with DAPI was added to the
dried cells, with a coverslip placed over the top and sealed with
clear nail polish. The slides were imaged under oil immersion
using a Zeiss LSM-800 microscope (×100 objective). Excitation
and emission used for the dyes were 358 and 463 nm for DAPI
and 578 and 603 nm for TMR-Star, respectively. A minimum of
three fields-of-view per slide was imaged; a total of 822 cells were
imaged, with an average of 19 cells per field-of-view. The images
were processed in Zeiss Zen Blue software.
Western Blot and Mass Spectrometry
Confirmation of the fusion of the SNAP-tag to HpdB was carried
out by anti-SNAP-tag western blotting and mass spectrometry
(MS). Samples were prepared by an overnight culture of 630Derm
PhpdB-CDS-SNAP being back-diluted to OD590nm of 0.5, and 1 ml
was added to BHIS ±2 mg/ml p-HPA and grown for 4 h. Following
growth, 10 ml of the cultures was pelleted and frozen at -80°C.TABLE 2 | Oligos used in this study.
Primer name Sequence (5’ to 3’) Use
hpdB CDS F ATGATTACGAAGATCTGAATTCGATAGGGTGTGC Amplification of hpdB promoter and coding sequence
hpdB CDS R GAGCTCGAATTTACACCCCTTCATACTCTGTTCTAGC Amplification of hpdB promoter and coding sequence
84151 hpdB + CDS F AGGGGTGTAAATTCGAGCTCGGTACCCG Amplification of pMTL84151 to clone hpdB promoter and coding sequence
84151 hpdB + CDS R ATTCAGATCTTCGTAATCATGGTCATATGGATACAG Amplification of pMTL84151 to clone hpdB promoter and coding sequence
hpdB Linker Vec F TGGGTAAATTCGAGCTCGGTACCCGGGGATCCTCT Amplification of pMTL84151 hpdB
hpdB Linker Vec R CACCACCAAGCACCCCTTCATACTCTGTTCTAGCAATTAC Amplification of pMTL84151 hpdB
Linker-SNAP F TGAAGGGGTGCTTGGTGGTGGAGGTTCAG Amplification of the linker and SNAP-tag sequence from Pfdx-SNAP
Linker-SNAP R GAGCTCGAATTTACCCAAGTCCTGGTTTC Amplification of the linker and SNAP-tag sequence from Pfdx-SNAP
hpdC qRT-PCR F GGATGCAACCAAAGGAATTTGT Used for qRT-PCR of hpdC
hpdC qRT-PCR R ACCCAGTCTTCTTTCTCTAGGC Used for qRT-PCR of hpdC
16S qRT-PCR F GGCAGCAGTGGGGAATATTG Used for qRT-PCR of 16S
16S qRT-PCR R CCGTAGCCTTTCACTCCTGA Used for qRT-PCR of 16SOctober 2021 | Volume 11 | Article 757599
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Tris-HCl, pH 8.0, 300 mM NaCl, 25 mM imidazole), transferred to
a lysis matrix B tube, and then ribolysed at 6.0 m/s for 40 s. The
samples were centrifuged, and the supernatant was saved. In
duplicate, for each culture sample, 15 µl of the supernatant was
added to 5 µl of 4X loading dye (Thermofisher), and the sample was
heated at 95°C for 5 min before loading onto two separate 10% Bis-
Tris gels which were run at 180 V, 400 A. One gel then underwent
transfer to a nitrocellulose membrane using the IBlot system as per
the instructions of the manufacturer; the other gel was saved for
excision of the appropriate band for mass spectrometry. The
membrane was washed in 1X phosphate-buffered saline (PBS)
Tween20 (0.1%) for 5 min before undergoing blocking with a
blocking buffer (5% whole milk in PBS Tween 20, 0.1%). Then, 10
ml blocking buffer, containing a 1:1,000 dilution of anti-SNAP
antibody (New England Biolabs), was added to the membrane and
incubated at room temperature for 1 h. The membrane was washed
three times in PBS Tween20 (0.1%) for 5 min. Moreover, 10 ml PBS
Tween20 (0.1%), containing a 1:10,000 dilution of IRDye CW800
goat anti-rabbit antibody (Li-cor), was added to the membrane and
incubated for 1 h before three 5-min wash steps in PBS Tween20
(0.1%). The membrane was visualized and imaged on an Odyssey
Li-cor instrument at the 800-nm wavelength. The HpdB–SNAP-tag
band was identified at 121 kDa, which was excised from the second
Bis-Tris gel and sent for mass spectrometry analysis at the Centre of
Excellence forMass Spectrometry at Kings College London. MS was
done as previously (Dawson et al., 2021), with the following
modifications: (1) 75 mM C18 column (50 cm length) was used
rather than 75 mM C18 column (15-cm length), (2) Xcalibur
software, v4.4.16.14, was used, (3) Proteome Discoverer software,
v2.5, was used, and (4) Scaffold 5 software, v5.0.1, was used. The
analysis of MS results was carried out in Scaffold software, v5.0.1,
and compared to the Uniprot All Taxonomy database. Six peptides
were identified as being from the HpdB of C. difficile strain 630, four
with 100% identity and two with 99% identity, providing a coverage
of 5.9% of the amino acid sequence of HpdB. The peptides
identified by MS are listed in Supplementary Table S1.RESULTS
Representatives of C. difficile Clades 3
and 5 Produce Significantly More p-cresol
From Tyrosine Fermentation
We have previously identified that p-cresol can be produced by
two distinct yet interrelated pathways: (i) directly from tyrosine
fermentation or (ii) alternatively from the turnover of exogenous
p-HPA (Harrison et al., 2020). In this study, we sought to
determine whether these two alternative mechanisms of
p-cresol production are conserved in representatives of each
C. difficile clade (Scheline, 1968; Dawson et al., 2011; Vardakas
et al., 2012; CDC, 2019; Brown et al., 2020) and whether there are
clade-specific differences in p-cresol production, which could
potentially contribute to virulence.
To assess clade-dependent p-cresol production, we identified
that the sequenced representatives of all five clades share at least
97.3% homology across the hpdBCA operon. We thenFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 6determined the expression level of the hpdBCA operon
controlling the production of the HpdBCA decarboxylase
responsible for the turnover of p-HPA to p-cresol, alongside
measuring the metabolites directly via HPLC. We show a
significant induction of the hpdBCA operon in the presence of
exogenous p-HPA, which is conserved in representative strains
from all five C. difficile lineages: clade 1, 630Derm (RT012); clade
2, R20291 (RT027); clade 3, CD305 (RT023); clade 4, M68
(RT017); and clade 5, M120 (RT078) (Figure 1A). The largest
fold change in the expression of the hpdC gene in response to p-
HPA was observed in strains R20291 (879.9 ± 331.0) and CD305
(792.7 ± 215.3), compared to 630Derm (469.4 ± 120.7), M68
(447.7 ± 153.0), and M120 (312.3 ± 98.9) (Figure 1A).
Using HPLC-DAD, we were able to differentially quantify p-
HPA and p-cresol production from (i) the fermentation of p-
tyrosine (without exogenous p-HPA) and (ii) the uptake and
turnover of exogenous p-HPA.
The fermentation of tyrosine in the five clades led to the
identification of significant differences in p-HPA and p-cresol
generation (Figure 1). M120, R20291, and CD305 produced the
highest levels of p-HPA at both 4 h (137, 66.5, and 45.7 µM,
respectively) and 8 h (228, 247, and 181 µM, respectively)
(Figures 1B, C). After 8 h of normalizing for growth, M120
produced significantly more p-HPA than 630Derm (p = 0.004),
CD305 (p = 0.018), and M68 (p < 0.001) (Figure 1C). As
anticipated, p-cresol production tracked with p-HPA
production from tyrosine fermentation (Figure 1). Strain
CD305 (RT023) produced the highest level of p-cresol at both
4 h (17.6 µM) and 8 h (42.2 µM) (Figures 1D, E). After 4 h, strain
CD305 produced significantly more p-cresol (0.0046 ± 0.0015
mg/ml) than 630Derm (0.0035 ± 0.0020 mg/ml, p < 0.001),
R20291 (0.0025 ± 0.0017 mg/ml, p = 0.017), and M68 (0.0014 ±
0.0001, p < 0.001). After 8 h of growth, strains CD305 (0.0046 ±
0.001 mg/ml) and M120 (0.0058 ± 0.0022 mg/ml) both produced
the highest levels of p-cresol, with strain M68 producing the least
p-cresol (p<0.005) (Figure 1E). This highlights the strain-specific
differences in p-cresol production, most likely as a result of the
differential rate of tyrosine fermentation to p-HPA.
As anticipated, all representatives of clades 1–5 were able to
uptake exogenous p-HPA and subsequently decarboxylate this to
p-cresol, producing 2.5 to 5.1 mM p-cresol at 8 h. We observed
an increase greater than 30-fold in p-cresol production in the
presence of exogenous p-HPA compared to the p-cresol
produced from tyrosine fermentation in all five strains
(Figure 1). Interestingly, after normalizing for growth, no
significant differences in p-cresol concentration were observed
under p-HPA induction, indicating that all five strains sense, take
up, and convert p-HPA with similar efficiency.
The HpdBCA Decarboxylase Is Produced
Ubiquitously in C. difficile Cells
To investigate the global response of cells within a given
C. difficile population to the metabolite p-HPA and to identify
the cellular localization of the HpdBCA decarboxylase
complex, a plasmid-based HpdB–SNAP-tag translational
fusion was constructed using a C. difficile-compatible plasmid
(pMTL84151) under control of the hpdBCA promoter. TheOctober 2021 | Volume 11 | Article 757599
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FIGURE 1 | hpdBCA expression, p-HPA, and p-cresol production by strains representing each of the C. difficile clades 1–5. (A) qRT-PCR was used to determine
whether p-HPA induces the expression of the hpdBCA operon across all five clades of C. difficile. Representative strains 630Derm (clade 1), R20291 (clade 2),
CD305 (clade 3), M68 (clade 4), and M120 (clade 5) were grown to exponential phase (OD590nm 0.6-0.7) in BHIS ±2 mg/ml p-HPA. The expression was normalized
to 16S rRNA control and analyzed by 2-DDCt. Data represents the mean of five biological replicates in technical triplicate, and their standard deviation with statistical
analysis was carried out by linear regression. The p-HPA and p-cresol concentrations were determined by high-performance liquid chromatography on samples from
each strain grown in defined media with or without 2 mg/ml exogenous p-HPA, with samples taken after 4 h (B, D) and 8 h (C, E). (B, C) p-HPA generation was
determined by the addition of p-HPA and p-cresol detected, and (D, E) p-cresol concentration was determined. The concentrations were normalized to growth (by
dividing the concentration by the OD590nm at the time the sample was taken). Data represents the mean and standard deviation of three independent replicates.
Statistical analysis was carried out by linear regression and used to determine significant differences between normalized p-HPA generation and p-cresol
concentrations for each strain. Statistically significant differences are indicated: *p < 0.05, **p < 0.01, ***p < 0.001.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org October 2021 | Volume 11 | Article 7575997
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linker to a SNAP-tag (Table 1). Confirmation of HpdB linked to
the SNAP-tag was carried out via western blot (Supplementary
Figure S1) and mass spectrometry, in which we identified six
peptides, four with 100% identity and two with 99% identity
unique to HpdB (Supplementary Table S1). Localization of
HpdB was visualized by confocal microscopy in 630Derm and
the p-cresol deficient mutant (hpdC::CT) carrying the HpdB–
SNAP-tag fusion (PhpdB-CDS-SNAP) in the presence and absence
of p-HPA to induce HpdBCA production. The SNAP-tag
substrate TMR-Star (excitation/emission: 578/603 nm) was
added to visualize the HpdB–SNAP-tag, and DAPI (excitation/
emission: 358/463 nm) was used to visualize DNA within the
cells. Confocal microscopy revealed that all cells grown in the
presence of p-HPA expressed the HpdB–SNAP-tag in response
to p-HPA, whereas those grown without p-HPA showed very
little or no visible expression (Figure 2). Furthermore, the
HpdB–SNAP-tag fusion was located throughout the cytoplasm
of the cell in the wild-type strain (Figure 2); however, in contrast,
the HpdB–SNAP-tag in the hpdC knockout strain was localized
in aggregates within the cells. This suggests that the HpdBCA
decarboxylase complex is formed and located throughout the
cytosol in all cells within a population of C. difficile in response to
p-HPA.
Mutation of CodY Leads to Reduced
p-HPA Turnover to p-Cresol
The regulation of the hpdBCA operon in response to exogenous
p-HPA is not yet completely understood. Here we identify that
CodY, a global transcriptional regulator that responds to the
presence of branched chain amino acids (Shivers and
Sonenshein, 2004) and GTP (Ratnayake-Lecamwasam et al.,
2001), indirectly activates p-cresol production (Figure 3).
Using a transcriptional fusion of the native hpdBCA promoter
fused to a phoZ reporter (PhpdB-phoZ), we show a reduction of
32.9 ± 13.7% in the expression of the hpdBCA operon in a CodY-
deficient mutant (DcodY) compared to its wild-type parental
strain, 630Derm, when grown in DM with exogenous p-HPA (2
mg/ml) (Figure 3C). This decrease in the expression of the
hpdBCA operon in the codYmutant is translated to a decrease in
the decarboxylation of p-HPA to p-cresol at both 4 and 8 h
(Figures 3A, B). This significant deficiency in turnover of
exogenous p-HPA to p-cresol was more pronounced at the
later growth stage (8 h), with 27.4% (± 2.2) turnover of p-HPA
in the codY mutant compared to 37.8% (± 1.2) in the wild type
(p = 0.004). We were unable to detect a significant difference in
the decarboxylation of p-HPA to p-cresol via tyrosine
fermentation (Supplementary Figure S2), suggesting that
CodY is involved in sensing and responding to exogenous p-
HPA, most likely indirectly as there is no CodY binding site
found in the promoter region (Dineen et al., 2010).
We show that the expression of the hpdBCA operon in all five
clades is induced in the presence of exogenous p-HPA and that
there are clade-specific differences in the rate of tyrosine
fermentation, resulting in the modulation of p-cresol production
(Figure 3). The regulation of HpdBCA decarboxylase is indirectlyFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 8controlled by the global regulator, CodY, which is known to
respond to nutrient availability (for a summary, see Figure 8).
p-HPA Adversely Affected the Growth of
C. difficile and Induced Sporulation
Given we have shown that C. difficile is able to produce p-cresol
from two interrelated pathways, (i) tyrosine metabolism and (ii)
uptake and utilization of exogeneous p-HPA, we set out to
determine if there is a selective pressure to undertake this
metabolite production. C. difficile strain 630Derm and a
630Derm hpdC inactivation mutant (hpdC::CT) were grown in
0, 1, 2, 3, and 4 mg/ml p-HPA and monitored over an 8 h time
course (Figure 4). A significant growth defect was observed at ≥2
mg/ml p-HPA in both wild type and hpdC::CT mutant, showing
that p-HPA is deleterious to C. difficile (Figure 4). Furthermore,
in the presence of 2 mg/ml p-HPA, the growth of the hpdC
mutant is significantly decreased compared to its wild-type
counterpart (p < 0.01) (Figure 4), showing that the efficient
turnover of p-HPA to p-cresol enhances the growth of C. difficile
over the 8 h time course. The growth defect observed in the
presence of p-HPA correlated with a significant decrease in total
viable counts (vegetative cells and spores) in both the wild-type
630Derm (Figure 5A) and the p-cresol deficient mutant
(Figure 5B), albeit more pronounced in the wild-type strain in
response to increasing concentrations of p-HPA. The analysis of
growth in the presence of p-HPA as a percentage of the BHIS-
only control showed that, at 1, 2, and 3 mg/ml p-HPA, growth
was reduced by 90.35 (± 1.52), 99.06 (± 0.41), and 99.71% (±
0.22), respectively, in the wild type compared to 24.61 (± 6.53),
48.43 (± 5.17), and 75.97% (± 7.71) in the hpdC::CT strain.
Alongside this drop in total viable counts, we observed a
significant increase in sporulation frequency, with a positive
correlation between p-HPA concentration and sporulation rate
(Figure 5C) and with a stronger correlation in the wild type
(R2 = 0.9193, p = 0.000012) than the hpdC::CT strain
(R2 = 0.8868, p = 0.00006), which suggests that both p-HPA
and p-cresol induce sporulation in C. difficile.
p-HPA Adversely Affects the Growth of
Representative Gram-Negative
Gut Bacteria
In addition to inhibiting the growth of C. difficile (Figures 4
and 5), p-HPA also inhibits the growth of commensal gut
bacteria, with a reduced growth rate in the presence of p-HPA
compared to their growth rate in media without p-HPA
supplementation (Figure 6). This reduced growth rate of the
Gram-negative species in the presence of increasing p-HPA
concentrations was more pronounced than the effects on
Gram-positive species (Figure 6). The growth of the
Gammaproteobacteria E. coli and K. oxytoca was significantly
inhibited by p-HPA (≥1 mg/ml), while P. mirabillis was
significantly inhibited at ≥2 mg/ml (Figure 6). In contrast,
increasing p-HPA concentrations had little effect on the
growth rate of the Gram-positive species B. adoscelentis and L.
fermentum, compared to their respective control media
(Figure 6). The growth of L. fermentum was only significantlyOctober 2021 | Volume 11 | Article 757599
Harrison et al. p-cresol Production by Clostridioides difficileinhibited at 4 mg/ml, and B. adoscelentis only exhibited a growth
defect at p-HPA concentrations of ≥3mg/ml (Figure 6).
Surprisingly, E. faecium was significantly more sensitive to p-
HPA than the other Gram-positive bacteria, exhibiting a
significant growth defect at 1 mg/ml p-HPA (Figure 6)
compared to its untreated control. Unlike the other Gram-
positive bacteria, C. difficile was unable to grow in p-HPA ≥4
mg/ml (Figure 4), showing that exogenous p-HPA is more
deleterious to C. difficile growth than other Gram-positiveFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 9bacteria (Figure 6). The growth curves demonstrate that,
relative to the growth rate of their untreated control, the
Gram-negative species are more sensitive to inhibition than the
Gram-positive species.
p-HPA Affects the Cell Membrane
Permeability of C. difficile
We have shown previously that p-cresol has a deleterious effect
on the membrane integrity of Gram-negative bacteria. Here weFIGURE 2 | Confocal microscopy to confirm the expression and determine the localization of HpdB. A plasmid-based translational fusion of HpdB was constructed
in C. difficile strain 630Derm, using the native hpdBCA promoter and hpdB coding sequence (without a stop codon) fused via a linker to the SNAP-tag to produce
PhpdB-CDS-SNAP. The expression of HpdB linked to the SNAP-tag was confirmed by anti-SNAP western and mass spectrometry. Cultures of C. difficile 630Derm
and hpdC::CT, each carrying PhpdB-CDS-SNAP, were grown for 4 h in BHIS ±2 mg/ml p-HPA, then harvested in the presence of the SNAP-tag substrate TMR-Star
before staining with Vectashield DAPI, and were imaged on a Zeiss LSM880 confocal microscope at 578-nm excitation and 603-nm emission (for TMR-Star) and
358-nm excitation and 463-nm emission for DAPI. The images are representative of three independent replicates.October 2021 | Volume 11 | Article 757599
Harrison et al. p-cresol Production by Clostridioides difficileshow that, similarly to p-cresol, p-HPA has a negative impact on
bacterial growth; therefore, we hypothesized that both p-cresol
and p-HPA may share a similar mechanism of toxicity, i.e.,
disruption of the cell envelope. To determine if this was the case,
we carried out phosphate release assays, as previously described
with p-cresol (Passmore et al., 2018), with measurements every
30 min up to 90 min of exposure to p-HPA. We compared
phosphate release in C. difficile strain 630Derm and E. coli at 0, 1,
2, and 3 mg/ml p-HPA to the maximum phosphate release. We
found significant increases in phosphate release at 2 mg/ml (p =
0.0013) for C. difficile (Figure 7A) and at 1 mg/ml for E. coli (p =
0.010) (Figure 7B). The addition of p-HPA to the growth media
reduces the pH in a concentration-dependent manner. To
investigate whether this phosphate release was due to the
acidification of the media in the presence of p-HPA, growth
curves (Supplementary Figures S3, S5) and phosphate release
assays (Figure 7) were undertaken in control media (0 mg/mlFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 10p-HPA) with the pH matched to that observed in TBS buffer in
the presence of p-HPA, i.e., pH levels 6.6, 4.1, and 3.8 were
equivalent to that for 1, 2, and 3 mg/ml p-HPA, respectively
(Figures 7C, D). In C. difficile, we observed a significant increase
in phosphate release at pH 3.8 (p = 0.0027), but not at pH 4.1 (p =
0.3039) or pH 6.6 (p = 0.545) when compared to the TBS control.
Furthermore, the highest percentage of maximum phosphate
release for C. difficile at low pH was only 86.5% (± 4.0) after 90
min at pH 3.8, in contrast to >95% after just 30 min in the
presence of 2 mg/ml p-HPA, rising to >99% at 90 min
(Figures 7A, C). Similarly, in E. coli, significant phosphate
release was seen at ≥1 mg/ml p-HPA, whereas when the pH
equivalent was tested (pH 6.6), phosphate release was actually
significantly reduced (p = 0.0184); furthermore, no significant
differences were observed in release at either pH 4.1 (p = 0.5757)
or pH 3.8 (p = 0.2155) when compared to the control
(Figures 7B, D).A B
C
FIGURE 3 | Mutation of codY reduces p-HPA conversion to p-cresol via a reduction in the expression of the hpdBCA operon. (A, B) 630Derm and 630Derm DcodY
were grown in defined media with 2 mg/ml p-HPA for 8 h, with the samples taken at 4 and 8 h for HPLC analysis of p-HPA and p-cresol concentration. The turnover
percentage was calculated as (p-cresol/p-HPA + p-cresol) normalized to growth by OD590 nm. (C) Expression from the hpdBCA promoter was assessed by
phosphatase activity in 630Derm and 630Derm DcodY carrying PhpdB-phoZ grown for 4 h in DM ±2 mg/ml p-HPA. Phosphatase activity was calculated by the
formula [OD420 nm – (OD550 nm x 1.75)] × 1,000/t (min) × OD590 nm × volume of cells (ml). Data represents the mean and standard deviation of three independent
replicates. Statistical analysis was carried out by linear regression and used to determine significant differences between normalized p-HPA turnover and promoter
reporter activity for each strain. *p < 0.05, **p < 0.01.October 2021 | Volume 11 | Article 757599
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(Supplementary Figure S3), which was found to be able to buffer
small pH changes (to a maximum of 0.52 ± 0.08), but not return the
growthmedia to neutral pH, which corresponds to unsupplemented
media (no p-HPA) (Supplementary Figure S4) and the
representative gut commensal species (Supplementary Figure
S5). Most strains, with the exception of L. fermentum, had a
slight growth defect in acidic media; however, the effect of acid
pH (Supplementary Figures S3 and S4) was not as dramatic as the
effect of growth in the presence of p-HPA. After 8 h, 2 mg/ml p-
HPA had a significant negative impact on the growth of C. difficile
(p = 0.0064), K. oxytoca (p = 0.0073), P. mirabillis (p = 0.0073), and
E. faecium (p = 0.0086), compared to growth in media without p-
HPA but at a matched pH (pH 6.2). The growth of E. coli at 3 mg/
ml p-HPA was significantly lower compared to growth at media
without p-HPA, pHmatched to pH 5.8 (p < 0.001) (Supplementary
Figure S4). However, the growth rate of both B. adoscelentis and L.
fermentum was similarly unaffected in both media containing p-
HPA and media with a matched pH, compared to the p-HPA.
Therefore, these assays have shown that p-HPA induces
phosphate release from the tested strains, resulting from the
disruption of the cell envelope, which is only compounded by the
acidity of p-HPA-supplemented media at the lowest pH. This
suggests that, similar to p-cresol, p-HPA affects membrane integrity.DISCUSSION
The importance of p-cresol production for C. difficile colonization
and pathogenesis combined with the recent finding that
exogenous p-HPA induces the expression of the hpdBCA operon
highlights the potential regulatory role for p-HPA in the virulence
of C. difficile through the modulation of p-cresol production. In
this study, we sought to identify whether p-cresol production inFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 11C. difficile from two interrelated pathways, (i) tyrosine metabolism
and (ii) uptake and utilization of exogeneous p-HPA, is conserved
throughout all the C. difficile lineages and to assess the effect that
exogenous p-HPA has on the viability of C. difficile and other
representative gut bacteria present in the healthy microbiome
(summarized in Figure 8).
The production of p-cresol is an important virulence attribute
for C. difficile, providing a competitive advantage over other
commensal gut bacteria to promote dysbiosis (Passmore et al.,
2018); however, the importance of its precursor p-HPA is yet to
be determined. p-HPA is produced by a range of bacteria found
in the gut, such as Clostridium and Klebsiella species, as well as by
mammalian cells (Wishart et al., 2018), which raises the
possibility of a pool of accessible p-HPA in the gut for
conversion by C. difficile to p-cresol. Here we present new
evidence that p-HPA is inhibitory to C. difficile growth and,
furthermore, that a C. difficile mutant unable to produce the
HpdBCA decarboxylase that converts p-HPA to p-cresol is
significantly more susceptible to growth inhibition by p-HPA.
This shows that the benefits of producing p-cresol are two-fold:
(i) p-cresol production enables C. difficile to outcompete other
gut bacteria and (ii) p-cresol production facilitates the
detoxification of p-HPA, which has a deleterious effect on C.
difficile growth (summarized in Figure 8).
There appears to be a selective advantage to drive p-cresol
production by C. difficile; however, we identified that there is also
a link between elevated p-HPA and increased sporulation rates in
both the wild type and HpdBCA-deficient mutant strain. We
have identified that the tyrosine metabolite p-HPA has a
deleterious effect on the growth of C. difficile, which results in
decreased total cell counts and increased sporulation; however,
there is a trade-off between the detoxification of p-HPA and the
production of p-cresol. We show that elevated p-cresol
production reduces total cell counts and concurrently increasesFIGURE 4 | Growth analysis of 630Derm and 630Derm hpdC::CT in the presence of p-HPA. Growth curves were undertaken in BHIS media supplemented with 0,
1, 2, 3, and 4 mg/ml p-HPA over an 8-h time course. The C. difficile strains 630Derm (circles) and the p-cresol null mutant hpdC::CT (squares) were compared. Data
represents the mean and standard deviation of three independent replicates. Statistical analysis was carried out by ANOVA, and significant differences are indicated:
**p < 0.01, ns, non significant.October 2021 | Volume 11 | Article 757599
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than in a p-cresol-deficient mutant, which indicates a lifestyle
choice of long-term survival (spore formation). This high-level
p-cresol production comes at a cost to C. difficile (reduced total
cell count); however, the benefit to C. difficile of promoting
dysbiosis in the gut, by selectively killing p-cresol-sensitive
Gram-negative species, results in a conserved mechanism of
actively driving the conversion of p-HPA to p-cresol. Taken
together, this suggests that there is a fine balance between p-HPA
turnover and p-cresol production. We have shown in a previous
study that p-cresol is deleterious to C. difficile growth when
produced at levels ≥9.5 mM, and here we show that p-HPA isFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 12inhibitory to Growth at high concentrations (2 mg/ml, 13.1
mM). Therefore, tight regulation of p-cresol production is
advantageous to C. difficile. The determination of p-HPA
availability in the gut over the course of CDI has not been
assessed and would be difficult to achieve due to the invasive
nature of the sample collection. However, there is evidence that
p-HPA is present in the human colon, and 19 µM p-HPA was
detected in human fecal samples (Jenner et al., 2005). In addition,
we previously showed that a p-cresol null mutant was at a
significant disadvantage compared to the wild type in a mouse
relapse model of CDI (Passmore et al., 2018). This is strong
evidence that sufficient p-tyrosine, p-HPA, or both are availableA B
C
FIGURE 5 | Effect of p-HPA and p-cresol on sporulation rate and total cell count. (A) 630Derm and (B) hpdC::CT were grown for 24 h in BHIS in the presence of 0,
1, 2, or 3 mg/ml p-HPA. Colony forming units (cfu) were performed per ml of culture for total cell counts and spore count (spores obtained by heating the culture at
65°C for 20 min) by plating on to BHIS plates containing 0.1% sodium taurocholate. (C) Percentage sporulation in 630Derm and hpdC::CT mutant in BHIS media
alone, or media supplemented with 1, 2 or 3 mg/ml p-HPA. Statistical analysis for a correlation between p-HPA concentration and sporulation rate was carried out
by Spearman one-tailed rank–order correlation. Statistical analysis to determine differences in total cell count was carried out by regression. Data represents the
minimum of three independent replicates, error bars represent standard deviation, and significant differences are indicated: *p < 0.05, **p < 0.01, ns, non significant.October 2021 | Volume 11 | Article 757599
Harrison et al. p-cresol Production by Clostridioides difficilefor C. difficile to produce p-cresol to maintain dysbiosis, as
evidenced by our observation of a concurrent fall in
Gammaproteobacteria in mice exposed to the wild type
compared to the p-cresol-null mutant (Passmore et al., 2018).
We observed previously (Harrison et al., 2020), as well as in this
study, that p-tyrosine fermentation to produce p-HPA and p-
cresol is extremely inefficient in vitro. Therefore, this suggests
that the utilization of exogenous p-HPA is an important source
of p-cresol production.
C. difficile is a genetically diverse species, which consists offive
clades (clades 1–5) (Griffiths et al., 2010; Stabler et al., 2012), andFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 13while three further cryptic clades have been identified, these are
likely to be a separate species (Dingle et al., 2014; Knight et al.,
2021). Variation exists both within and between clades in major
virulence factors, such as toxin production (Akerlund et al., 2008;
Merrigan et al., 2010), motility (Valiente et al., 2012), and
sporulation (Akerlund et al., 2008). Significant examples of this
include strains of clade 4 that do not have functional toxin A
(Kuijper et al., 2001; Drudy et al., 2007) and clade 5 isolates
which are non-motile, such as M120 (Valiente et al., 2012), yet
despite this diversity in virulence attributes between clades, the





FIGURE 6 | Analysis of the growth of C. difficile and gut commensal species in the presence of p-HPA. Six representative gut commensal species,three Gram-
positive: (A) Bifidobacterium adoscelentis, (B) Enterococcus faecium, (C) Lactobacillus fermentum, and three Gram-negative; (D) Eschericia coli, (E) Klebsiella
oxytoca, (F) Proteus mirabilis strains were grown in BHIS media with 0, 1, 2, 3, and 4 mg/ml p-HPA. Growth curves represent three biological replicates.
ANOVA was used to determine significant differences between growth curves. Error bars represent standard deviation, and significant differences are indicated:
*p < 0.05, **p < 0.01, ***p < 0.001, ns, non significant .October 2021 | Volume 11 | Article 757599
Harrison et al. p-cresol Production by Clostridioides difficileInterestingly, the more genetically divergent cryptic clades also
carry hpdBCA-like operons. The alignments of the DNA
sequences of these operons to hpdBCA from strain 630 showed
identities of 91.1, 95.0, and 92.2% for cryptic clades C-I, C-II, and
C-III, respectively (Supplementary Figure S6). Therefore, our
finding that strains representative of clades 1–5 all show a high-
level induction of the hpdBCA operon and high levels of p-cresol
production in the presence of p-HPA suggests that this response
is very well conserved and therefore of importance to C. difficile
and, by extension, possibly CDI pathogenesis. Furthermore,
given that the conversion of exogenous p-HPA to p-cresol was
consistent among all representatives of clades 1–5, these findings
imply that these lineages have similar capacities to transport p-
HPA into the cell and convert it to p-cresol.
p-cresol can be produced via two pathways: firstly, from the
metabolism of p-tyrosine and, secondly, from the uptake and
decarboxylation of exogenous p-HPA. We identified that strains
CD305 (RT023) and M120 (RT078) were the most efficient
producers of p-HPA from p-tyrosine fermentation, whereas strain
M68 (RT017) was the least efficient. There was a direct correlation
between the ability to produce p-HPA from p-tyrosine fermentation
and the subsequent conversion to p-cresol, which indicates strain-
specific differences in the proficiency of p-tyrosine utilization.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 14Interestingly, these higher p-cresol-producing strains, RT023 and
RT078, are among the most prevalent ribotypes identified in the UK
(PHE, 2019). It is noteworthy that the fermentation of p-tyrosine to
p-HPA under these conditions is inefficient, which limits the ability
to produce p-cresol. The level of p-cresol produced from p-tyrosine
fermentation in the conditions tested is a minimum of 72.6-fold
lower after 8 h compared to p-cresol produced from exogenous
p-HPA. While these differences provide evidence for variation in
p-tyrosine fermentation in vitro, the in vivo utilization of p-tyrosine
may differ depending on the local availability of nutrients. In
support of this, we have previously shown that environmental
conditions affect p-cresol production in vitro, where we observed
that production is significantly lower in rich media (BHIS)
than less rich media (yeast peptone) (Dawson et al., 2011).
This further suggests that exogenous p-HPA is a major source of
p-cresol production.
When looking at the impact of p-cresol and p-HPA on
representative strains of gut species, we found that p-HPA had
a similar effect to our published data on the effect of p-cresol
(Passmore et al., 2018), with both compounds being generally
more toxic to Gram-negative species than Gram-positive ones.
Both K. oxytoca and E. coli were significantly inhibited by




FIGURE 7 | Assessing the effect of p-HPA compared to pH on the membrane integrity of C. difficile compared to E. coli. (A, B) Phosphate release assays were
carried out in Tris-buffered saline (TBS) with 0, 1, 2, and 3 mg/ml p-HPA in C. difficile and E. coli, respectively. (C, D) TBS was acidified to pH 6.6, 4.1, and 3.8,
respectively, with the addition of hydrochloric acid, to match the pH of the phosphate release assays undertaken in the presence of p-HPA. Statistical analysis was
undertaken using ANOVA to compare phosphate release in p-HPA or acidified TBS to the TBS control. Data represents the mean and standard deviation of three
independent replicates. Significant differences are indicated: *p < 0.05, **p < 0.01, ***p < 0.001, ns, non significant.October 2021 | Volume 11 | Article 757599
Harrison et al. p-cresol Production by Clostridioides difficilebacteria were highly resistant to both p-HPA and p-cresol, with
the exception of E. faecium that was significantly inhibited at this
concentration. Interestingly, p-HPA is acidic; therefore, we
sought to determine whether the effect of p-HPA on the
growth of C. difficile and the Gram-negative gut bacteria was a
result of the acidification of the environment by p-HPA. FurtherFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 15analysis by testing acidic pH levels via growth curves, as well as
utilization of a phosphate release assay, provided evidence that
the mechanism of toxicity of p-HPA is not limited to its
acidification of the environment, as in addition, p-HPA also
disrupts cell envelope integrity, a further similarity to p-cresol
(Passmore et al., 2018).FIGURE 8 | The schematic indicates the interconnected roles of the microbiome and host cells in p-cresol production by C. difficile and the impact of p-cresol
production on the Gram-negative Gammaproteobacteria within the host microbiome.October 2021 | Volume 11 | Article 757599
Harrison et al. p-cresol Production by Clostridioides difficileThe mechanisms controlling p-cresol production by C.
difficile centers around the transcriptional regulation of the
hpdBCA operon in response to p-HPA. We identified that p-
HPA activates regulatory factors to initiate transcription. Here
we provide evidence of the first such regulator to be involved in
this process: the global regulator CodY. The deletion of codY
renders C. difficile less able to convert p-HPA to p-cresol as a
result of the reduced expression of the hpdBCA operon
(Figure 8). This is likely to be an indirect effect as no CodY
binding site has been identified directly upstream of the hpdBCA
operon (Dineen et al., 2010). However, CodY is a global regulator
with over 350 binding sites identified through the genome, 37 of
which are located near to regulatory genes (Dineen et al., 2010),
one of which could be the factor directly responsible for the high
level of induction of the hpdBCA operon. Alternatively, the
deletion of CodY may have led to an impaired ability for the
bacteria to take up p-HPA. Steglich et al. have shown that R20291
CDR20291_805 and _806 are part of an ABC transporter which
imports tyrosine (Steglich et al., 2018); this transporter is
controlled by CodY (Dineen et al., 2010). However, they did
not assess the ability of this ABC transporter system to uptake p-
HPA. Therefore, we could speculate that the tyrosine import
system may also import p-HPA.
Importantly, we have identified that every cell in a given
population responded strongly to the presence of exogenous p-
HPA via the transcription and translation of a SNAP-tagged
HpdB subunit. However, p-tyrosine fermentation by C. difficile in
vitro produced insufficient p-HPA to observe the induction of
HpdB by SNAP tag visualization. A mutant deficient in the
HpdC subunit of the HpdBCA decarboxylase complex provided
evidence that all three subunits of HpdBCA are responsible for
facilitating the trafficking of the enzyme throughout the cell.
Given that every cell expressed HpdBCA in response to
exogenous p-HPA, this clearly demonstrates that p-cresol
production is not a virulence factor expressed heterogeneously
within a population, such as pneumolysin in Streptococcus
pneumoniae (Surve et al., 2018) or type three secretion systems
in Salmonella typhimurium (Sturm et al., 2011). This indicates
instead that the response to p-HPA is ubiquitous throughout a
population as well as conserved within the species. This may
suggest that the conversion of p-HPA to p-cresol by C. difficile is
important to the survival of an individual cell as well as the
wider population.
In conclusion, our results provide new insights into the
impact of p-HPA on the viability of C. difficile and other
bacterial species in the gut microbiome (Figure 8). We found
that, in addition to C. difficile benefiting from p-HPA induction
of p-cresol contributing to dysbiosis, it also benefits from the
efficient removal of p-HPA from the immediate environment, as
p-HPA is deleterious to C. difficile growth. Our findings
underscore the importance of the response to p-HPA by
demonstrating that every cell exposed to p-HPA responds with
a high level of induction of HpdBCA decarboxylase, which is
conserved in the C. difficile species. Rationally designed
inhibitors of HpdBCA could be both highly specific and an
effective target to reduce problematic C. difficile.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 16DATA AVAILABILITY STATEMENT
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Supplementary Figure S1 | Confirmation of HpdB–SNAP fusion. Samples were
grown in the presence and absence of 2 mg/ml p-HPA before undergoing western
blot analysis. The indicated band was approximately the right size for the HpdB–
SNAP fusion (121 kDa). The band was excised from a duplicate gel, and the
presence of the HpdB–SNAP fusion was confirmed by mass spectrometry.
Supplementary Figure S2 | p-Cresol production from 630Derm and 630Derm
DcodY. Each strain was grown in defined media for 8 h. Samples were taken after 4
and 8 h and were analyzed by HPLC for p-cresol concentration. p-Cresol
concentration was normalized to growth (as measured by OD590nm) at the time the
sample was taken. Regression analysis was used to determine significant
differences between strains in p-cresol production.
Supplementary Figure S3 | Growth of C. difficile in pH matched to the presence
of p-HPA. C. difficile strain was grown in BHIS alongside BHIS, with the pH lowered
to 6.6, 6.2, 5.8, and 5.4 to match the pH found at 1, 2, 3, and 4 mg/ml p-HPA,
respectively. Statistical analysis by ANOVA was used to determine differences inOctober 2021 | Volume 11 | Article 757599
Harrison et al. p-cresol Production by Clostridioides difficilegrowth at different pH levels. Error bars represent standard deviation, and data
represents the minimum of three independent replicates. Significant differences are
indicated: *p < 0.05, **p < 0.01, ***p < 0.001.
Supplementary Figure S4 | Growth of C. difficile in acidic BHIS media. 630Derm
(black bars) and 630Derm hpdC::CT (gray bars) strains were grown in BHIS
alongside BHIS, with the pH lowered to 6.6, 6.2, 5.8, and 5.4 to match the pH found
at 1, 2, 3, and 4 mg/ml p-HPA, respectively, with the final pH measured after 24 h of
growth. Regression analysis was used to determine whether there were any
significant differences in the final pH between the two strains at each starting pH.
Error bars represent standard deviation, and data represents the minimum of three
independent replicates. ns, non-significant.
Supplementary Figure S5 | Growth of gut commensals in pH matched to the
presence of p-HPA. Each strain was grown in BHIS alongside BHIS, with the pH
lowered to 6.6, 6.2, 5.8, and 5.4 to match the pH found at 1, 2, 3, and 4 mg/mlFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 17p-HPA, respectively. Representative Gram-positive (A-C) and representative Gram-
negative (D- F) gut bacteria were assessed. Statistical analysis by ANOVA was
used to determine differences in growth at different pH levels. Error bars represent
standard deviation, and data represents the minimum of three independent
replicates, where no significant difference was observed (indicated with ns).
Supplementary Figure S6 | Alignment of hpdBCA-like operons carried by
cryptic clades C-I, C-II, and C-III to hpdBCA operon from 630. Alignments were
carried out using the Emboss Needle software from EMBL-EBI.
Supplementary Table S1 | Peptides identified by mass spectrometry of HpdB–
SNAP-tag. An anti-SNAP-tag western blot was run to probe the presence of HpdB
fused to the SNAP-tag. Mass spectrometry was used to confirm the identity of the
tested protein. Analysis was carried out in Scaffold, v5.0.1, searching Uniprot’s All
Taxonomy database. Peptides identified as HpdB are listed. The peptides provide
5.9% of the complete HpdB protein sequence.REFERENCES
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